299660 셀리드

기본 정보

• 섹터: KOSDAQ:일반서비스
• 시가총액: 414억원 (2026-06-30 기준)
• 첫 등장: 2026-06-26 (누적 1일)
• 태그: 매크로/바이오헬스 · 항암백신 · 면역치료 · CDMO · 바이오벤처 · 아데노바이러스벡터
• 네이버 금융: 🔗

기업개요

• 동사는 2006년 항암면역치료백신 및 COVID-19 예방백신 개발 전문 바이오벤처기업으로 설립되었으며, 2019년 코스닥시장에 기술성장기업으로 상장하였음.
• 2024년 포베이커를 흡수합병하여 이커머스 사업부를 신설하였음.
• 자체 원천기술인 CeliVax 기반 BVAC 시리즈 항암면역치료백신과 아데노바이러스 벡터 기반 COVID-19 예방백신을 개발하고 있으며, 자체 GMP시설을 활용하여 CMO 및 CDMO 사업을 전개하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-14	1,918	1,820	🔵 -5.11%	—	×0.2	🔻 개인	-2.6억	-2.6	+0.0	+0.0	+0.0	+2.5	+0.0
2026-08-13	1,948	1,918	🔵 -1.54%	—	×0.1	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	-0.0
2026-08-12	1,920	1,948	🔴 +1.46%	—	×0.3	🟢 외인	+1.6억	+1.6	+0.0	+0.0	+0.0	-1.6	+0.0
2026-08-11	1,683	1,920	🔴 +14.08%	—	×1.1	🟢 외인	+1.6억	+1.6	+0.0	-0.0	+0.0	-1.6	-0.0
2026-08-10	1,680	1,683	🔴 +0.18%	—	×0.1	🔻 개인	+0.3억	+0.3	+0.0	+0.0	+0.0	+0.4	-0.7
2026-08-07	1,778	1,680	🔵 -5.51%	—	×0.2	⚫ 그외	-1.1억	-1.1	+0.0	+0.0	+0.0	+0.4	+0.8
2026-08-06	1,707	1,778	🔴 +4.16%	—	×0.4	🟢 외인	+2.4억	+2.4	+0.0	+0.0	+0.0	-2.4	-0.1
2026-08-05	1,707	1,707	⚪ +0.00%	—	×0.3	🟢 외인	+0.5억	+0.5	+0.0	+0.0	+0.0	-0.5	-0.0
2026-08-04	1,727	1,707	🔵 -1.16%	—	×0.2	🟢 외인	+0.1억	+0.1	+0.0	-0.0	+0.0	+0.0	-0.1
2026-08-03	1,707	1,727	🔴 +1.17%	—	×0.9	🔻 개인	-0.4억	-0.4	+0.0	+0.1	+0.0	+0.3	+0.1
2026-07-31	1,688	1,707	🔴 +1.13%	—	×2.5	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.1	-0.1
2026-07-30	1,780	1,688	🔵 -5.17%	—	×4.7	🔻 개인	-1.2억	-1.2	+0.0	+0.0	+0.0	+1.4	-0.2
2026-07-29	1,777	1,780	🔴 +0.17%	—	×32.8	🔻 개인	-2.4억	-2.4	+0.0	+0.0	+0.0	+2.4	-0.0
2026-07-28	1,367	1,777	🔴 +29.99%	—	×5.2	🔻 개인	-3.2억	-3.2	+0.0	+0.0	+0.0	+3.3	-0.1
2026-07-27	1,052	1,367	🔴 +29.94%	—	×2.2	⚫ 그외	-0.4억	-0.4	+0.0	+0.0	+0.0	+0.1	+0.3
2026-07-24	1,082	1,052	🔵 -2.77%	—	×0.5	🔻 개인	-0.5억	-0.5	+0.0	+0.0	+0.0	+0.5	-0.0
2026-07-23	1,025	1,082	🔴 +5.56%	—	×1.1	🟢 외인	+0.3억	+0.3	+0.0	-0.0	+0.0	-0.3	+0.0
2026-07-22	1,033	1,025	🔵 -0.77%	—	×0.7	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.7	+0.0
2026-07-21	1,071	1,033	🔵 -3.55%	—	×1.4	🔻 개인	-0.0억	-0.0	+0.0	-0.0	+0.0	+0.0	+0.0
2026-07-20	1,136	1,071	🔵 -5.72%	—	×0.5	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.4	+0.0
2026-07-16	1,147	1,136	🔵 -0.96%	—	×0.5	🟢 외인	+1.1억	+1.1	+0.0	+0.0	+0.0	-1.1	+0.0
2026-07-15	1,121	1,147	🔴 +2.32%	—	×0.4	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-14	1,155	1,121	🔵 -2.94%	—	×0.6	🟢 외인	+1.1억	+1.1	+0.0	+0.0	+0.0	-1.1	+0.0
2026-07-13	1,255	1,155	🔵 -7.97%	—	×0.7	🟢 외인	+0.5억	+0.5	+0.0	+0.0	+0.0	-0.5	+0.0
2026-07-10	1,275	1,255	🔵 -1.57%	—	×0.8	🔻 개인	-0.9억	-0.9	+0.0	-0.0	+0.0	+0.9	+0.0
2026-07-09	1,345	1,275	🔵 -5.20%	—	×0.6	🔻 개인	-0.3억	-0.3	+0.0	+0.0	+0.0	+0.3	-0.1
2026-07-08	1,417	1,345	🔵 -5.08%	—	×0.6	🔻 개인	-0.8억	-0.8	+0.0	+0.0	+0.0	+0.7	+0.1
2026-07-07	1,430	1,417	🔵 -0.91%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-07-06	1,443	1,430	🔵 -0.90%	—	×0.4	🔻 개인	-0.4억	-0.4	+0.0	+0.0	+0.0	+0.3	+0.1
2026-07-03	1,427	1,443	🔴 +1.12%	—	×0.6	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.6	-0.1
2026-07-02	1,534	1,427	🔵 -6.98%	—	×0.7	🔻 개인	-1.0억	-1.0	+0.0	+0.0	+0.0	+1.1	-0.1
2026-07-01	1,406	1,534	🔴 +9.10%	—	×2.8	🟢 외인	+5.0억	+5.0	+0.0	+0.0	+0.0	-5.2	+0.3
2026-06-30	1,950	1,406	🔵 -27.90%	—	×10.5	🔻 개인	-0.8억	-0.8	+0.0	+0.0	+0.0	+0.6	+0.2
2026-06-29	2,785	1,950	🔵 -29.98%	—	×0.9	⚫ 그외	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.1	+0.1
2026-06-26	2,430	2,785	🔴 +14.61%	—	×2.2	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-25	2,430	2,430	⚪ +0.00%	—	×0.6	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-06-24	2,400	2,430	🔴 +1.25%	—	×0.7	🔻 개인	-0.8억	-0.8	+0.0	+0.0	+0.0	+0.8	+0.0
2026-06-23	2,675	2,400	🔵 -10.28%	—	×1.2	🟢 외인	+0.2억	+0.2	+0.0	+0.0	-0.2	-0.0
2026-06-22	2,760	2,675	🔵 -3.08%	—	×1.0	🔻 개인	-0.7억	-0.7	+0.0	+0.0	+0.7	+0.0
2026-06-19	2,620	2,760	🔴 +5.34%	—	×3.5	🔻 개인	-3.3억	-3.3	+0.0	+0.0	+3.3	+0.0
2026-06-18	2,705	2,620	🔵 -3.14%	—	×0.7	🔻 개인	-0.9억	-0.9	+0.0	+0.0	+0.9	+0.0
2026-06-17	2,470	2,705	🔴 +9.51%	—	×1.6	🟢 외인	+3.3억	+3.3	+0.0	-2.2	-1.1	+0.0
2026-06-16	2,480	2,470	🔵 -0.40%	—	×0.4	🔻 개인	-0.3억	-0.3	+0.0	+0.0	+0.3	+0.0
2026-06-15	2,535	2,480	🔵 -2.17%	—	×0.5	🔻 개인	-1.0억	-1.0	+0.0	+0.0	+1.0	+0.0
2026-06-12	2,395	2,535	🔴 +5.85%	—	×0.5	🔻 개인	-0.7억	-0.7	+0.0	+0.0	+0.7	+0.0
2026-06-11	2,390	2,395	🔴 +0.21%	—	×0.5	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.1	+0.0
2026-06-10	2,490	2,390	🔵 -4.02%	—	×0.6	🟢 외인	+0.6억	+0.6	+0.0	+0.0	-0.6	+0.0
2026-06-09	2,545	2,490	🔵 -2.16%	—	×0.6	🔻 개인	-1.3억	-1.3	+0.0	+0.0	+1.3	+0.0
2026-06-08	2,765	2,545	🔵 -7.96%	—	×0.7	🟢 외인	+2.2억	+2.2	+0.0	-0.0	-2.2	+0.0
2026-06-05	2,855	2,765	🔵 -3.15%	—	×0.2	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.1	-0.0
2026-06-04	2,800	2,855	🔴 +1.96%	—	×0.2	🟢 외인	+0.4억	+0.4	+0.0	+0.0	-0.4	-0.1
2026-06-02	2,775	2,800	🔴 +0.90%	—	×0.3	⚫ 그외	-0.0억	-0.0	+0.0	+0.0	-0.1	+0.1
2026-06-01	3,000	2,775	🔵 -7.50%	—	×0.7	🟢 외인	+0.3억	+0.3	+0.0	-0.0	-0.4	+0.1
2026-05-29	3,035	3,000	🔵 -1.15%	—	×0.2	🔻 개인	-0.4억	-0.4	+0.0	+0.0	+0.4	+0.0
2026-05-28	3,280	3,035	🔵 -7.47%	—	×0.3	🔻 개인	-2.1억	-2.1	+0.0	+0.0	+2.0	+0.0
2026-05-27	3,350	3,280	🔵 -2.09%	—	×0.7	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1
2026-05-26	3,265	3,350	🔴 +2.60%	—	×0.4	🟢 외인	+0.5억	+0.5	+0.0	+0.0	-0.3	-0.1
2026-05-22	3,050	3,265	🔴 +7.05%	—	×0.3	🟢 외인	+2.8억	+2.8	+0.0	+0.0	-3.0	+0.2

일자별 사유 (최신 위)

2026-08-11

• 사유: —
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -949억)
• 매크로 원인: 제약·바이오 개별 임상·허가 호재 잇따르며 급등 (통풍신약 3상 성공, 이상지질혈증제 허가 등) (높음)

2026-07-28

• 사유: 바이오맥짚기 언급, 임상 충격 후 낙폭과대 반등
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +203억)
• 매크로 원인: 코스닥 7.7% 급락장에서 개별 임상·실적 모멘텀 보유 바이오만 역행 급등 (보통)

2026-07-27

• 사유: 6월 3상 실패 급락 후 낙폭과대 반발 매수 추정
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -111억)
• 매크로 원인: 임상·실적 개별 모멘텀 산발 — 코스닥 반등 국면에서 바이오 저가주 순환매 (낮음)

2026-06-26

• 사유: 코로나 백신 AdCLD-CoV19-1 OMI 3상 결과 공시 + 신규변이 수혜
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -747억)
• 매크로 원인: 셀리드 코로나19 백신 3상 임상결과 공시 + 신규변이 BA.3.2.2 면역회피 이슈로 코로나 백신주 부각 (높음)